Awards
2009
Gilda's Club of Rochester Jacob Gitelman Award
2007
Hematology-Oncology Fellowship Teaching Award
2005 - 2007
Aplastic Anemia and MDS International Foundation Gordon Forgash Research Award
2004 - 2006
Lawrence A. Kohn Senior Teaching Fellowship
Sponsor: University of Rochester Department of Medicine
1998 - 2003
Leukemia Society of America, Clinical Scholar Award
1989 - 1992
Leukemia Society of America Special Fellowship
1989 - 1992
James P. Wilmot Postdoctoral Cancer Research Fellowship
1987 - 1988
American Cancer Society Clinical Fellowship Award
VIEW ALL expand_more
Clinical Trials
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications (NMDP 10-CBA)
Lead Researcher: Jane Larae Liesveld MD
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
View Study Details
Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia
Lead Researcher: Jane Larae Liesveld MD
A phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when administered following induction chemotherapy, consolidation chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a 1:1 ratio to receive either crenolanib in addition to standard first line treatment of AML (chemotherapy and if eligible, transplantation) (arm A) or midostaurin and standard treatment (arm B). Potentially eligible subjects will be registered and tested for the presence of FLT3 mutation. Once the FLT3 mutation status is confirmed and additional eligibility is established, subject will be randomized and enter into the treatment phase.
View Study Details
Publications
Journal Articles
3/14/2023
Zhang H, Liesveld JL, Calvi LM, Lipe BC, Xing L, Becker MW, Schwarz EM, Yeh SA. "The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies." Bone research.. 2023 Mar 14; 11(1):15. Epub 2023 Mar 14.
12/15/2022
Locastro M, Sanapala C, Mendler JH, Norton SA, Bernacki R, Carroll T, Klepin HD, Watson EE, Liesveld JL, Huselton EJ, O'Dwyer KM, Baran AM, Flannery M, Kluger B, Loh KP. "Adaptation of Serious Illness Care Program to be Delivered via Telehealth for Older Patients with Hematologic Malignancy." Blood advances.. 2022 Dec 15; Epub 2022 Dec 15.
11/2/2022
Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park JH, Wieduwilt MJ, Jeyakumar D, Yaghmour G, Atallah E, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow MR, Stone RM, Sharon E, Erba HP. "Dasatinib/Prednisone Induction Followed by Blinatumomab/Dasatinib in Ph+ Acute Lymphoblastic Leukemia." Blood advances.. 2022 Nov 2; Epub 2022 Nov 02.
Books & Chapters
2017
Chapter Title: Stem Cell Mobilization
Book Title: In: Encyclopedia of Cancer
Author List: Liesveld, JL
Edited By: Schwab, M
Published By: Springer-Verlag 2017
2016
Chapter Title: Acute Myelogenous Leukemia
Book Title: In: Williams Hematology
Author List: Liesveld, JL and Lichtman, MA
Edited By: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri MA
Published By: McGraw Hill 2016 in New York, NY
2016
Chapter Title: Chronic Myelogenous Leukemia and Related Disorders
Book Title: In: Williams Hematology
Author List: Liesveld, JL and Lichtman, MA
Edited By: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri MA,
Published By: McGraw Hill 2016 in New York, NY
VIEW ALL PUBLICATIONS